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OAB. METHODS: The USS is a ﬁve-point rating scale of urinary
urgency that is completed at the time of each micturition. A
survey was mailed to urologists and gynecologists that asked
them to review the USS and complete the evaluation items. OAB
patients were recruited through an advertisement in a newspa-
per to participate in a one-time qualitative interview (cognitive
debrieﬁng). Patients were screened to ensure the presence of OAB
symptoms. Patients reviewed the USS and various wording and
response options. Patients were then cognitively debriefed using
standardized questions to determine their interpretation of the
scale, their understanding of urinary urgency, and the ease with
which the USS could be completed. RESULTS: Five physicians
completed the mail surveys. Twelve patients with a mean age of
53 (67% women) were cognitively debriefed. The physicians and
patients reported that the USS was appropriate, relevant, and
understandable. The patients found the deﬁnition of urinary
urgency to be clear and easy to comprehend, and they were able
to discriminate among the response options describing urinary
urgency. Patients denied having problems completing the USS
after each micturition. CONCLUSIONS: Overall, the physicians
and patients found the USS to be easy to understand and rele-
vant to urinary urgency. Content validity was established for the
USS.
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OBJECTIVE: To evaluate the impact of patient selection crite-
ria on baseline characteristics and selected outcomes in a cohort
of patients with overactive bladder (OAB). METHODS: Newly
diagnosed OAB patients were identiﬁed from a medical and
pharmacy claims database including more than 30 geographi-
cally diverse managed care plans. Two patient cohorts were com-
pared for baseline characteristics, treatment status, and incidence
of selected urologic conditions following diagnosis. The ﬁrst
group required only one claim with an OAB diagnosis (DX1);
the second required a conﬁrmatory claim (DX2). RESULTS: A
total of 113,061 DX1 and 39,863 DX2 patients were identiﬁed.
Mean ages for DX1 men and women were 60y and 52y, respec-
tively; mean ages for DX2 men and women were 57y and 49y,
respectively. In total, 28% of DX2 patients and 10% of DX1
patients received pharmacologic treatment. Of those untreated,
49% were men in DX2 group and 41% in DX1 group. In total,
26% of DX2 women and 20% of DX1 women had baseline uro-
logic infections, and 17% of DX2 women and 12% of DX1
women had baseline urologic disorders. A total of 11% of DX2
men and 9% of DX1 men had baseline urologic infections, and
28% of DX2 men and 21% of DX1 men had baseline benign
prostatic hyperplasia. In DX2 patients, the adjusted odds of
urinary tract infection was 0.77 (95% CI, 0.73–0.80); in DX1
patients, the same estimate was 1.19 (95% CI, 1.14–1.24).
CONCLUSIONS: Patients with one OAB diagnostic claim dif-
fered in demographic and clinical characteristics from those with
a conﬁrmatory claim. Furthermore, differences in percentages of
patients receiving OAB treatment may suggest that health-
seeking behaviors differ among patients with one and two diag-
nostic claims. These data support the use of a conﬁrmatory
diagnostic claim in some studies of OAB.
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OBJECTIVES: Previous studies report that women with urge
urinary incontinence (UUI) symptoms are more bothered than
women with stress urinary incontinence (SUI) symptoms.
However, studies have not examined the relative bother of stress
and urge symptoms among women who experience both.
METHODS: A survey was mailed to 5130 women using a
national access panel and 3562 (69%) questionnaires were com-
pleted. Our analysis focuses on women with symptoms of both
SUI and UUI in the previous seven days. Women were asked
which type of symptom they would most like to get rid of. 
Frequency was categorized as stress predominant (more stress
leakages than urge leakages), equal, or urge predominant. Inter-
ference with everyday life was rated on a scale from zero “not
at all” to ten “a great deal.” RESULTS: In total, 3364 ques-
tionnaires met study criteria (age 18–60 and not pregnant); 359
(11%) women reported both types of UI symptoms, 162 stress
predominant, 146 equal frequency, and 51 urge predominant. In
women with equal frequency, 44% desired most to be rid of
stress symptoms, and 56% urge symptoms (p = 0.15 vs. alter-
native of no preference). Among stress predominant women,
62% most desired to be rid of stress symptoms while 76% of
urge predominant women most desired to be rid of urge symp-
toms (p < 0.0001). Interference with everyday life was 4.6 (3.2
SD) for stress symptoms and 4.8 (3.2 SD) for urge symptoms.
CONCLUSIONS: Among women with mixed incontinence
symptoms, relative bother of SUI and UUI is dependent on fre-
quency and types of leakages. Majority of women desired to be
rid of the symptom with the higher frequency. Interference with
daily activities is not signiﬁcantly different for the two types of
symptoms. This emphasizes importance of physicians assessing
mixed patients for symptom predominance and targeting the
more bothersome type of UI for initial treatment.
